CWM, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
CWM, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$23
-20.7%
496
-2.9%
0.00%
Q2 2023$29
+52.6%
5110.0%0.00%
Q1 2023$19
+18.8%
511
-11.3%
0.00%
Q4 2022$16
-99.9%
576
-0.2%
0.00%
Q3 2022$16,000
-20.0%
577
+2.5%
0.00%
Q2 2022$20,000
+5.3%
563
+6.4%
0.00%
Q1 2022$19,000
+280.0%
529
+129.0%
0.00%
Q4 2021$5,0002310.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders